Corella Dolores, Ordovás José M
Unidad de Epidemiología Genética y Molecular. Departamento de Medicina Preventiva y Salud Pública, Ciencias de la Alimentación, Toxicología y Medicina Legal. Universidad de Valencia. CIBER Fisiopatología de la Obesidad y Nutrición. Instituto de Salud Carlos III, Madrid..
Department of Cardiovascular Epidemiology and Population Genetics, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid. IMDEA Alimentación, Madrid. Spain. Nutrition and Genomics Laboratory, JM-USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA. USA..
Nutr Hosp. 2015 Feb 26;31 Suppl 3:177-88. doi: 10.3305/nh.2015.31.sup3.8765.
One of the main problems in nutritional epidemiology is to assess food intake as well as nutrient/food component intake to a high level of validity and reliability. To help in this process, the need to have good biomarkers that more objectively allow us to evaluate the diet consumed in a more standardized, valid and precise way has often been commented upon. There are various definitions of biomarkers and also different classifications of the same. In general a biomarker can be defined as a characteristic that can objectively measure different biological samples and that can be evaluated as an exposure marker of normal or pathogenic biological processes or of responses to a certain intervention. The biological samples most commonly used in nutritional epidemiology are blood, red blood cells, plasma, serum, urine, nails, saliva, faeces and samples of different tissues. Exposure biomarkers (dietary intake), biomarkers of effects and biomarkers of disease status can be determined from these samples. In turn, exposure biomarkers can be temporarily categorized into markers of acute, medium term or chronic effects. Many difficulties arise in identifying good biomarkers. Currently, advances in omics are opening up new possibilities for obtaining new biomarkers of various kinds, using genomics, epigenomics, transcriptomics, lipidomics, proteomics and metabolomics. We shall review the present situation of biomarkers in nutritional epidemiology as well as the future trends of the new omic biomarkers.
营养流行病学的主要问题之一是要将食物摄入量以及营养素/食物成分摄入量评估到高度的有效性和可靠性。为了辅助这一过程,人们常常提到需要有良好的生物标志物,以便更客观地让我们能够以更标准化、有效和精确的方式评估所摄入的饮食。生物标志物有多种定义,对其分类也各不相同。一般来说,生物标志物可定义为一种能够客观测量不同生物样本的特征,并且可被评估为正常或致病生物过程的暴露标志物,或是对某种干预措施的反应标志物。营养流行病学中最常用的生物样本是血液、红细胞、血浆、血清、尿液、指甲、唾液、粪便以及不同组织的样本。从这些样本中可以确定暴露生物标志物(饮食摄入量)、效应生物标志物和疾病状态生物标志物。反过来,暴露生物标志物可暂时分为急性、中期或慢性效应标志物。在识别良好的生物标志物方面存在许多困难。目前,组学技术的进展为利用基因组学、表观基因组学、转录组学、脂质组学、蛋白质组学和代谢组学获取各类新的生物标志物开辟了新的可能性。我们将综述营养流行病学中生物标志物的现状以及新型组学生物标志物的未来趋势。